STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $479,000 | -36.0% | 99,050 | +40.6% | 0.00% | – |
| Q4 2019 | $749,000 | +29.4% | 70,450 | +26.8% | 0.00% | – |
| Q3 2019 | $579,000 | -13.1% | 55,550 | +27.8% | 0.00% | – |
| Q2 2019 | $666,000 | +15.2% | 43,450 | -3.3% | 0.00% | – |
| Q1 2019 | $578,000 | +35.4% | 44,950 | 0.0% | 0.00% | – |
| Q4 2018 | $427,000 | -45.5% | 44,950 | -4.8% | 0.00% | – |
| Q3 2018 | $784,000 | +0.1% | 47,230 | -3.3% | 0.00% | – |
| Q2 2018 | $783,000 | +5.4% | 48,830 | +0.5% | 0.00% | – |
| Q1 2018 | $743,000 | -6.8% | 48,610 | -4.8% | 0.00% | – |
| Q4 2017 | $797,000 | +63.7% | 51,080 | +16.4% | 0.00% | – |
| Q3 2017 | $487,000 | +39.9% | 43,880 | +15.8% | 0.00% | – |
| Q2 2017 | $348,000 | -7.2% | 37,880 | -13.7% | 0.00% | – |
| Q1 2017 | $375,000 | -13.4% | 43,900 | +8.7% | 0.00% | – |
| Q4 2016 | $433,000 | – | 40,400 | +100900.0% | 0.00% | – |
| Q3 2014 | $0 | – | 40 | +300.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 10 | -98.2% | 0.00% | – |
| Q3 2013 | $26,000 | +85.7% | 570 | 0.0% | 0.00% | – |
| Q2 2013 | $14,000 | – | 570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |